Target intelligence / Profile preview

MADCAM1 antisense RNA 1 (MADCAM1-AS1)

Target
MADCAM1-AS1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

MADCAM1 antisense RNA 1 (MADCAM1-AS1) is a long non-coding RNA gene transcribed from the opposite strand of the MADCAM1 region. Unlike MADCAM1, which encodes an endothelial adhesion protein involved in mucosal immunity, MADCAM1-AS1 does not encode a protein and has no confirmed therapeutic target status. Its biological function, disease relevance, and utility as a drug target or biomarker remain uncharacterized in current scientific resources. Key clarifications: MADCAM1-AS1 is not a protein, not a receptor, not an enzyme, and does not have established therapeutic target status. The entry may be based on a misunderstanding or is incomplete; MADCAM1 (the protein-coding gene) is a completely different, well-characterized therapeutic target implicated in inflammation and is a target of drugs such as ontamalimab, but MADCAM1-AS1 is not. If you intended information on the protein-coding MADCAM1 ("Mucosal vascular addressin cell adhesion molecule 1"), that molecule is a well-established therapeutic target, with numerous drugs and disease associations. In contrast, MADCAM1-AS1 is a non-coding RNA with limited characterization and currently not recognized as a druggable molecular target.

Other names
MADCAM1-AS1
02

Biological functions

No experimentally confirmed biological functions specific to MADCAM1-AS1 are currently reported in publicly available databases or literature
03

Disease associations

No specific disease association has been conclusively established to date for MADCAM1-AS1

Beyond the preview

Go deeper on MADCAM1 antisense RNA 1 (MADCAM1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MADCAM1 antisense RNA 1 (MADCAM1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call